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ORIGINAL RESEARCH
Diazoxide Maintains Human Myocyte Volume Homeostasis
During Stress
Sara K. Maffit, BS; Angela D. Sellitto, MS; Ashraf S. Al-Dadah, MD; Richard B. Schuessler, PhD; Ralph J. Damiano, Jr, MD;
Jennifer S. Lawton, MD
Background—-Exposure to hypothermic hyperkalemic cardioplegia, hyposmotic stress, or metabolic inhibition results in significant
animal myocyte swelling (6% to10%) and subsequent reduced contractility (10% to 20%). Both are eliminated by the adenosine
triphosphate-sensitive potassium channel opener diazoxide (DZX). The relationship between swelling and reduced contractility
suggests that the structural change may represent one mechanism of postoperative myocardial stunning. This study evaluated
human myocyte volume during stress to investigate if similar phenomena exist in human myocytes.
Methods and Results—-Human atrial myocytes isolated from tissue obtained during cardiac surgery were perfused with Tyrode’s
physiological solution (20minutes, 37◦C), test solution (20minutes), and Tyrode’s (37◦C, 20minutes). Test solutions (n=6 to 12my-
ocytes each) included Tyrode’s (37◦C or 9◦C), Tyrode’s+DZX (9◦C), hyperkalemic cardioplegia (9◦C)±DZX, cardioplegia+DZX+HMR
1098 (sarcolemmal adenosine triphosphate-sensitive potassium channel inhibitor, 9◦C), cardioplegia+DZX+5-hydroxydeconoate
(mitochondrial adenosine triphosphate-sensitive potassium channel inhibitor, 9◦C), mild hyposmotic solution±DZX, metabolic
inhibition±DZX, and metabolic inhibition+DZX+5-hydroxydeconoate. Myocyte volume was recorded every 5 minutes. Exposure to
hypothermic hyperkalemic cardioplegia, hyposmotic stress, or metabolic inhibition resulted in significant human myocyte swelling
(8%, 7%, and 6%, respectively; all P<0.05 vs control). In all groups, the swelling was eliminated or lessened by DZX. The addition of
channel inhibitors did not significantly alter results.
Conclusions—-DZX maintains human myocyte volume homeostasis during stress via an unknown mechanism. DZX may prove
to be clinically useful following the elucidation of its specific mechanism of action. ( J Am Heart Assoc. 2012;1:jah3-e000778
doi: 10.1161/JAHA.112.000778.)
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P reviously, our laboratory documented the detrimentalconsequences of three stresses (metabolic inhibition [MI],
mild hyposmotic stress, and exposure to hypothermic hy-
perkalemic cardioplegia) on myocyte volume and contractil-
ity in isolated animal (rabbit and mouse) myocytes.1–4 All
three stresses resulted in significant myocyte swelling (6% to
10%) and an associated decline in contractility (10% to 20%)
in both species. In both species, diazoxide (DZX, adenosine
triphosphate-sensitive potassium (KATP) channel opener) pre-
vented the detrimental swelling.1–4
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Interestingly, the prevention of the detrimental myocyte
swelling (structural derangement) resulted in elimination of
the associated reduced contractility (functional derangement).
We have proposed that volume derangement and function are
inversely related and thatmyocyte swelling secondary to stress
may represent one mechanism of myocardial stunning.4
Openers of the KATP channel have been demonstrated to
limit ischemic injury, preserve myocardial function, mimic is-
chemic preconditioning, and alleviate the effect of myocardial
stunning in multiple models.5–9 However, the mechanism of
cardioprotection is unknown. Multiple theories exist regarding
the proposed mechanism of cardioprotection provided by KATP
channel openers. Theories implicate both the sarcolemmal and
purported mitochondrial KATP (mKATP) channels as well as KATP
channel-independent effects of the pharmacological openers
themselves.10–14 The cardioprotection observed by opening
the KATP channel, or the channel openers themselves, may
involve the maintenance of volume homeostasis (and contrac-
tility) at the myocyte level.
The current study was devised to establish the relevance
of observations in animal tissue to those in human tissue to
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support subsequent use in humans. This study was performed
to determine if human myocytes undergo similar significant
swelling secondary to exposure to hyperkalemic cardioplegia,
mild hyposmotic stress, and MI and if the KATP channel opener,
DZX, would prevent this detrimental consequence.
Methods
Experiments were approved by the Washington University Hu-
man Studies Committee in accordance with Institutional Re-
view Board approval and patients gave informed consent for
participation.
Human Myocyte Isolation
Normally discarded tissue specimens (right or left atrium)
were collected during elective cardiac surgery with patient
consent. Tissue was immediately placed into 37◦C oxy-
genated calcium-free Tyrode’s physiological solution (Tyr) (in
mmol/L): NaCl 130, KCl 5, KH2PO4 0.4, MgCl2 3, HEPES (N-[2-
hydroxethyl]piperazine-N′-[4-butanesulfnonic acid]) 5, taurine
15, glucose 10, and creatine 5.7 (pH adjusted to 7.3 by 20%
NaOH titration), Na2EGTA 0.1, and nitrilotriacetic acid 6 (NTA,
Sigma Chemical Corporation, St. Louis, MO) and taken imme-
diately to the laboratory (5 minutes), where they were placed
into fresh oxygenated 37◦C calcium-free Tyr with 0.1 mmol/L
Na2EGTA and 6 mmol/L NTA, and minced. Minced tissue was
transferred to a flask containing 20 mL of 37◦C calcium-free
Tyr with 6 mmol/L NTA and agitated in a 37◦C water bath
at 100 rpms for 12 minutes to remove extracellular calcium.
Tissue was then transferred to a flask containing 10 mL of
37◦C calcium-free Tyr with 1000 mg/L bovine serum albumin
(Sigma Chemical Corporation), 925 mg/L collagenase type II
(Worthington Biomedical, Freehold, NJ), and 250 mg/L pro-
tease (Sigma Chemical Corporation) and agitated in a 37◦C
water bath at 100 rpms for 70 minutes. This solution was
then centrifuged at 100g at 4◦C for 5 minutes. The super-
natant was discarded and the pellet resuspended in 15 mL
of 37◦C calcium-free Tyr with 1000 mg/L bovine serum albu-
min (Sigma Chemical Corporation) and 925 mg/L collagenase
type II (Worthington Biomedical) and agitated in a 37◦C water
bath at 100 rpms for 20 minutes. This solution was then cen-
trifuged at 100g at 4◦C for 5 minutes. The previous two steps
were then repeated. The supernatant was discarded and the
pellet resuspended in a 37◦C cell isolation solution contain-
ing (in mmol/L): potassium glutamate 120, KCl 10, KH2PO4
10, MgSO4 1.8, K2EGTA 0.5, taurine 10, HEPES 10, and glu-
cose 20, and triturated to separate the cells. This solution was
then filtered through 300 micron nylon mesh to remove large
debris and centrifuged at 100g at 4◦C for 10 minutes. The
supernatant was discarded and the pellet resuspended in cell
isolation solution and centrifuged again at 100g at 4◦C for 10
minutes, three times. The supernatant was then discarded and
the pellet resuspended in cell isolation solution and allowed to
settle for 30 minutes.15–17
Myocyte Imaging
Myocytes were used immediately on the day of isolation and
were not cultured. Myocytes were visualized on a slide on a
glass-bottom chamber on an inverted microscope stage (Leitz,
Wetzlar, Germany) as previously described.4 An aliquot of the
isolated cells was placed into the chamber and allowed to sta-
bilize for 5 minutes, after which the chamber was perfused
at a rate of 3 mL/min with Tyrode’s physiological control so-
lution (in mmol/L): NaCl 130, KCl 5, CaCl2 2.5, MgSO4 1.2,
NaHCO3 24, Na2HPO4 1.75, and glucose 10 (buffered to a pH
of 7.4 using 95% O2 to 5% CO2). Cells were evaluated for viabil-
ity based on the following criteria: normal rod shape, smooth
edges, sharp borders, clear striations, absence of blebbing,
and lack of spontaneous contractions.18 Only viable cells were
used. Cell length, width, and area were manually traced using
Scion Image software (Scion Corporation, Frederick, MD) and
estimated as previously described.4,18
Experimental Protocol
Cells were perfused for 20 minutes with 37◦C control Tyr to
obtain baseline volume. Any changes in cell volume secondary
to the isolation or imaging protocol would be evident dur-
ing this period. Myocytes were then perfused for 20 minutes
with test solution followed by a 20 minutes reexposure period
with 37◦C control Tyr. Test solutions included control Tyr (Tyr
37◦C, N=12), Tyr 9◦C (N=12), Tyr+100 μmol/L DZX (Sigma
Chemical Corporation) (Tyr+DZX 9◦C, N=12), St. Thomas hy-
perkalemic cardioplegia (Plegisol; Abbott Laboratories, North
Chicago, IL) (St. T 9◦C, N=12), St. T+100 μmol/L DZX (St.
T+DZX 9◦C, N=12), St. T+100 μmol/L DZX+40 μmol/L
HMR1098 (Aventis PharmaDeutschlandGmbh, Frankfurt, Ger-
many) (St. T+DZX+HMR10989◦C,N=12), St. T+100μmol/L
DZX+50 μmol/L 5-hydroxydeconoate (5-HD, Sigma Chemical
Corporation) (St. T+DZX+5-HD 9◦C, N=12), altered Tyr (1T
37◦C, control for osmotic experiments,N=9), hyposmotic solu-
tion (0.9T 37◦C,N=9), hyposmotic solution+100μmol/L DZX
(0.9T+DZX 37◦C, N=9), MI (37◦C, N=6), MI+100 μmol/L
DZX (MI+DZX 37◦C, N=6), and MI+100 μmol/L DZX+50
μmol/L 5-HD (MI+DZX+5-HD 37◦C, N=6).
St. Thomas hyperkalemic cardioplegia consisted of (in
mmol/L): NaCl 110, NaHCO3 10, KCl 16, MgCl2 16, and CaCl2
1.2, and was equilibrated with 95% O2 to 5% CO2 and titrated to
the pH of 7.3 with 10% NaHCO3 solution. The addition of DZX
did not significantly alter solution osmolarity (298±5 mOsm).3
Altered Tyrode’s solution (1T) served as the control for the
hyposmotic stress experiments. The 1T solution was made by
substituting 130 mmol/L D-mannitol for 130 mmol/L NaCl in
normal Tyrode’s solution. The hyposmotic solution (0.9T) was
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made by substituting 97.5mmol/LD-mannitol for 130mmol/L
NaCl in normal Tyrode’s solution. This solution was used as
this degree of hyposmotic stress provided a similar amount
of myocyte swelling as that of hyperkalemic cardioplegia in
animal studies, and this degree of swelling was ameliorated by
DZX in animal myocytes.2
The MI solution provided complete MI, and this solution has
been documented to provide significant myocyte swelling in
animal myocytes.4 The solution consisted of (in mmol/L): NaCl
130, KCl 5, CaCl2 2.5, MgSO4 1.2, NaHCO3 24, 2 deoxyglucose
10, and NaCN 2.
DZX is a purported mKATP channel opener. The dose of
100 μmol/L ameliorated cell swelling secondary to stress in
previous animal studies.1–4 HMR 1098 is a purported specific
sarcolemmal KATP (sKATP) channel inhibitor and it was added to
hyperkalemic cardioplegia in an attempt to eliminate any sKATP
channel activity. 5-HD is a purported specific mKATP channel
inhibitor and it was added during exposure to hyperkalemic
cardioplegia and to MI in an attempt to eliminate any mKATP
channel activity. The dose of 100 μmol/L DZX, 50 μmol/L 5-
HD, and 40μmol/L HMR 1098were chosen based on previous
experiments using animal myocytes.1,4 Stock solutions were
made by dissolving 5-HD in double deionized water, HMR 1098
in double deionized water, and DZX in 0.1% dimethyl sulfoxide.
Dimethyl sulfoxide has no effect on cell volume.18
The perfusion temperature of 37◦C for control Tyr was cho-
sen to mimic normal physiological temperature. The perfusion
temperature of 9◦C was chosen as it approximates myocardial
temperature during cardioplegic arrest and is the tempera-
ture at which animal myocytes exhibited significant swelling
during exposure to hyperkalemic cardioplegia. Myocytes were
not subjected to any period of ischemia or modified ischemia
as to eliminate any confounding cellular changes caused by
ischemic stress.
Volume estimations were made after 5 minutes of exposure
to control Tyr and every 5 minutes thereafter.
Statistical Analysis
All data are presented as mean±standard error of the mean. A
repeated measures analysis of variance was used for sequen-
tial time-based measurements for each test solution against
its own baseline and control values. Using Fisher’s least sig-
nificant different test, post hoc multiple comparisons between
different test groups were made separately during the base-
line, test solution, and reexposure periods. Probability values
<0.05 were considered significant. A Shapiro-Wilks test was
used to test for normality. If the data failed the normality test, a
nonparametric (Friedman’s nonparametric repeated measures
comparison) was used. Statistical analysis was preformed
using SyStat 10.2 (SyStat Corporation, Point Richmond,
CA).
Figure 1. Representative isolated human myocyte surrounded by
cellular debris at 40× magnification via inverted microscope.
Results
Up to three myocytes per patient sample were used with cells
randomly assigned to treatment groups. The yield of viable
myocytes for human tissue was approximately 30% per field.
A representative viable myocyte is depicted in Figure 1.
Myocyte Volume
The mean length, width, and area of myocytes at baseline were
102.33±1.38 μm, 24.44±0.35 μm, and 2228.06±44.31
μm2, respectively. Assuming that the cross-section of the my-
ocytes was a square, the mean volume of a single myocyte at
baseline was 27.04±1.17 pico liter. However, if cells are actu-
ally cylindrical, this initial assumption would over estimate cell
volume by a factor of 4/π or 1.27.19 To avoid this uncertainty,
cell volume changes are presented relative to baseline values
(which were calculated assuming the baseline volume was a
square) taken during perfusion with control solution.
During perfusion of control Tyr (37◦C), cell volume remained
stable throughout the entire experimental period (Figure 2).
Perfusion with 9◦C Tyr resulted in a significant increase in cell
volume (2.06±0.69%, P<0.001 vs Tyr 37◦C). On reexposure to
Tyrode’s at 37◦C, cell volume returned to baseline (Figure 2).
Perfusion with 9◦C Tyr with DZX resulted in a lesser degree of
cell swelling (1.19±0.35%, P<0.05 vs Tyr 37◦C, P=NS vs Tyr
9◦C). On reexposure to Tyrode’s at 37◦C, cell volume returned
to baseline (Figure 2).
Perfusion with 9◦C St. Thomas hyperkalemic cardioplegic
solution resulted in the greatest amount of cell swelling
(8.09±0.59%; P<0.001 vs all other groups). On reexpo-
sure to Tyrode’s at 37◦C, cell volume returned to baseline
(Figure 2). The addition of 100 μmol/L DZX to St. T 9◦C elim-
inated the significant cell swelling (P=NS vs Tyr 37◦C). The
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Figure 2. Diazoxide, amitochondrial adenosine triphosphate-sensitive potassium channel opener, eliminates humanmyocyte swelling secondary
to hypothermic hyperkalemic cardioplegia. After a 20 minutes period of exposure to control 37◦C Tyrode’s physiological solution (Tyr 37◦C),
isolated myocytes were exposed to test solution for 20 minutes (n=12 in each), and then reexposure to Tyr 37◦C for 20 minutes. Cell volume
change is represented as percent change from baseline (y axis) vs time (x axis). (*P<0.05 vs Tyr 37◦C, +P<0.05 vs St. T 9◦C).
addition of 40 μmol/L HMR 1098 or 50 μmol/L 5-HD to St.
Thomas+DZX 9◦C did not alter cell volume (Figure 3).
During perfusion of 1T Tyr (control solution for osmotic alter-
ation experiments), myocyte volume remained stable through-
out the entire experimental period (Figure 4). During exposure
to hyposmotic solution (0.9T), myocyte volume significantly
increased (7.15±0.25%, P<0.05 vs 1T solution), and this was
reduced to only a 1% volume increase by the addition of DZX
(Figure 4).
During exposure to MI, myocyte volume significantly in-
creased (5.95±4.15%, P<0.05 vs control), and this was re-
duced to only 1% to 3% volume increase with the addition of
DZX (Figure 5). Cell volume in theMI+DZX group did not return
to normal on reexposure to Tyr. Cell volume was not signifi-
cantly different from control Tyrode’s when 50 μmol/L 5-HD
was added to the MI+DZX 37◦C group (Figure 5).
Discussion
Isolated animal myocytes demonstrate significant swelling and
reduced contractility during exposure to hypothermic hyper-
kalemic cardioplegia, MI, or hyposmotic stress.1–4,15,18 DZX
prevents these detrimental consequences secondary to all
three stresses in two animal species.1–4 These detrimental
consequences may be potentiated when the stresses are
combined in situations such as cardiac surgery, and these
changes may underlie one mechanism of postoperative my-
ocardial stunning. This study was conducted to investigate if
the same phenomena are observed in human myocytes.
This study confirmed that significant myocyte swelling oc-
curs in isolated human myocytes secondary to exposure to
hyperkalemic cardioplegia, hyposmotic stress, and MI. This
significant swelling was eliminated or lessened by the addition
of DZX (a known KATP channel opener) with or without pharma-
cological inhibition of the KATP channel. This confirmation of
responses in human myocytes is vital to any future translation
to clinical use.
Hypothermic hyperkalemic cardioplegia or exposure to hy-
posmotic stress results in myocyte swelling because of expo-
sure to a hyposmolar extracellular environment. In contrast,
MI results in myocyte swelling because of the development of
a hyperosmolar intracellular environment. Interestingly, DZX
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Figure 3. Sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channel inhibitors do not alter human myocyte volume
response to hyperkalemic cardioplegia in the presence of diazoxide. After a 20 minutes period of exposure to control 37◦C Tyrode’s physiological
solution (Tyr 37◦C), isolated myocytes were exposed to test solution for 20 minutes (n=12 in each), and then reexposure to Tyr 37◦C for 20
minutes. Cell volume is represented as percent change from baseline (y axis) vs time (x axis). (*P<0.05 vs Tyr 37◦C, +P<0.05 vs St. T 9◦C).
(by an unknown mechanism) provides cellular volume home-
ostasis by lessening or eliminating myocyte swelling during
exposure to all three stresses.
It is not known if the beneficial effect of DZX observed in
isolated myocytes is related to cardioprotective effects that
have been documented at the whole organ or the organism
level. We propose that myocyte swelling (which we have shown
to be associated with decreased contractility) may be one
mechanism of myocardial stunning. DZX may therefore pro-
vide protection by maintaining myocyte volume homeostasis
during stress. In this fashion, observations at the cellular level
may provide mechanistic insight into responses at the organ
level.
The exact mechanism of action of the KATP channel opener
DZX has remained elusive. DZX may provide myocyte volume
homeostasis during stress at the KATP channel itself or at a
channel-independent location.20–22 KATP channels have been
described on both sKATP and mKATP membranes. Opening of
the sarcolemmal channel results in K+ efflux from the cell, and
opening the mKATP channel is proposed to result in K+ influx
from the cytosol into the mitochondria.
To attempt to localize the site of DZXs mechanism of ac-
tion, a purported mitochondrial channel inhibitor, 5-HD, and
a purported sarcolemmal channel inhibitor, HMR 1098, were
separately added to hypothermic St. Thomas solution contain-
ing DZX. In addition, 5-HD was added to MI solution containing
DZX. Neither channel inhibitor altered the observed decrease
in cell swelling associated with DZX during exposure to stress.
This is consistent with observations in animal myocytes.1–4
This finding may be related to the nonspecificity of channel
inhibitors or it may support a KATP channel-independent mech-
anism of DZX.23,24 A non-sKATP channel location of action is
also supported by definitive experiments using mouse whole-
cell voltage clamp and sKATP channel subunit Kir6.2 knockout
mice.25
The genetic structure of the sKATP channel has been de-
termined; however, the structure of the proposed mitochon-
drial channel has not. Therefore, claims of channel opening
and inhibition are often implied with use of pharmacological
manipulation. The specificity of KATP channel openers and in-
hibitors has been challenged, introducing uncertainty to the
isolated use of pharmacological manipulation.23,24 Alternative,
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Figure 4. Mild hyposmotic stress results in significant human myocyte swelling that is ameliorated by the addition of diazoxide. After a 20
minutes period of exposure to control 37◦C 1T Tyrode’s physiological solution (1T 37◦C), isolated myocytes were exposed to test solution for
20 minutes (n=9 in each), and then reexposure to 1T 37◦C for 20 minutes. Cell volume is represented as percent change from baseline (y axis)
vs time (x axis). (*P<0.05 vs 1T, +P< 0.05 vs 0.9T+DZX). 1T is altered Tyrode’s solution (control) and 0.9T is hyposmotic solution (0.9 times
normal).
KATP channel-independent targets of DZX have been proposed
and will be the focus of future work.26 The determination of
DZXs mechanism of action warrants further investigation and
will be greatly aided by the determination of a mKATP channel
genetic identity.
Significantmyocyte swelling (2%) secondary to hypothermia
alone (hypothermic control Tyrode’s solution) was observed in
this study. This swelling was much less than that observed
following exposure to hypothermic St. Thomas solution (8%),
hyposmotic stress (7%), or MI (6%). This observation is not
consistent with previous observations in animal ventricular
myocytes.1–4 The addition of DZX to hypothermic Tyr did de-
crease swelling due to hypothermia alone by 50%, which is
consistent with the hypothesis that KATP channel openers play
a role in myocyte volume homeostasis. However, this finding
in human myocytes suggests that the additive effect of three
stresses (hypothermia and ischemia and exposure to hyper-
kalemic cardioplegia as in cardiac surgery) could be detrimen-
tal to myocyte function. This clearly warrants further investi-
gation.
In addition, human myocyte volume tended to demonstrate
a prolonged increase in cell size during stress (hyperkalemic
cardioplegia or osmotic stress) and a prolonged return to nor-
mal volume on reexposure to Tyrode’s solution (particularly
in the MI group) in contrast to animal myocytes and previous
work in human myocytes15. Variations in isolation methods,
species differences, individual patient comorbidities, potential
differences in the speed with which the test solutions reached
the myocyte bath, and other differences such as the use of
human atrial myocytes versus the use of animal ventricular
myocytes may account for these results.
Study Limitations
Isolated myocytes are advantageous because they allow for
repeated estimations of cell volume. This model is not intended
tomimic the clinical situation of ischemia and reperfusion. This
model allows for the independent evaluation of one stress at
a time and a more careful evaluation of the effects of KATP
channel openers. Caution must therefore be taken in applying
these findings to the whole organ or organism level.
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Figure 5. Metabolic inhibition results in significant human myocyte swelling that is ameliorated by the addition of diazoxide. After a 20 minutes
period of exposure to control 37◦C Tyrode’s physiological solution (Tyr 37◦C), isolated myocytes were exposed to test solution for 20 minutes
(n=6 in each), and then reexposure to Tyr 37◦C for 20 minutes. Cell volume is represented as percent change from baseline (y axis) vs time
(x axis). (*P<0.05 vs Tyr, +P<0.05 vs MI+DZX).
The solutions evaluated in this study were crystalloid so-
lutions, which may result in myocyte swelling. However, any
baseline myocyte swelling due to isolation procedures in this
study would be evident in the control Tyr group. Comparisons
to control crystalloid solution and the representation of all data
as a percentage of baseline should correct for any direct effect
of the solutions themselves. In addition, crystalloid solutions
were used in order to be consistent with previous work using
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